Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow
Sign Up to like & getrecommendations! Published in 2025 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2025.2493077
Abstract: ABSTRACT Introduction Although different novel beta-lactam/beta-lactamase inhibitor combinations (BL/BLIc) were recently licensed, resistance occurrence have been reported up to 15% of Gram-negative pathogens. For this reason, novel BL/BLIc of tomorrow will be released for managing… read more here.
Keywords: lactam beta; beta lactamase; lactamase inhibitor; beta ... See more keywords